Earlier this month, AmTrust filed a defamation suit against short sellers and an equity research firm accusing the defendants of attempting to manipulate the Nasdaq-listed insurer's stock price by publishing "false and misleading" statements.
Earlier this month, AmTrust filed a defamation suit against short sellers and an equity research firm accusing the defendants of attempting to manipulate the Nasdaq-listed insurer's stock price by publishing "false and misleading" statements.